Request Sample Inquiry

Human Insulin Market

Human Insulin Market

Human Insulin Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

148

Base Year:

2022

Nov - 2022

Format:

Report Code:

VMR-1911

Segments Covered

By Product Drugs, Delivery Devices
By Product Type Insulin Analoys & Biosimilars, Human Insulin Biologics
By Diabetes Type Diabetes 1, Diabetes 2
By Delivery Devices Pens, Pen Needles, Syringes
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 22.66 Billion
Revenue 2030:	USD 28.71 Billion
Revenue CAGR (2023 - 2030):	3.00%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Human Insulin Market - Segment Analysis
1. Overview
2. Global Human Insulin Market, 2016 - 2028 (USD Million)
3. Global Human Insulin Market - by Product
  1. By Drugs
  2. By Delivery Devices
4. Global Human Insulin Market - by Product Type
  1. By Insulin Analoys & Biosimilars
  2. By Human Insulin Biologics
5. Global Human Insulin Market - by Diabetes Type
  1. By Diabetes 1
  2. By Diabetes 2
6. Global Human Insulin Market - by Delivery Devices
  1. By Pens
  2. By Pen Needles
  3. By Syringes
7. Global Human Insulin Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Human Insulin Market - Segment Analysis
1. Overview
2. North America Human Insulin Market, 2016 - 2028 (USD Million)
3. North America Human Insulin Market, by Product
  1. By Drugs
  2. By Delivery Devices
4. North America Human Insulin Market, by Product Type
  1. By Insulin Analoys & Biosimilars
  2. By Human Insulin Biologics
5. North America Human Insulin Market, by Diabetes Type
  1. By Diabetes 1
  2. By Diabetes 2
6. North America Human Insulin Market, by Delivery Devices
  1. By Pens
  2. By Pen Needles
  3. By Syringes
7. North America Human Insulin Market, by Country
  1. U.S.
    1. U.S. Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. U.S. Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. U.S. Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. U.S. Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  2. Canada
    1. Canada Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Canada Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Canada Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Canada Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  3. Mexico
    1. Mexico Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Mexico Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Mexico Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Mexico Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
Europe Human Insulin Market - Segment Analysis
1. Overview
2. Europe Human Insulin Market, 2016 - 2028 (USD Million)
3. Europe Human Insulin Market, by Product
  1. By Drugs
  2. By Delivery Devices
4. Europe Human Insulin Market, by Product Type
  1. By Insulin Analoys & Biosimilars
  2. By Human Insulin Biologics
5. Europe Human Insulin Market, by Diabetes Type
  1. By Diabetes 1
  2. By Diabetes 2
6. Europe Human Insulin Market, by Delivery Devices
  1. By Pens
  2. By Pen Needles
  3. By Syringes
7. Europe Human Insulin Market, by Country
  1. Germany
    1. Germany Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Germany Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Germany Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Germany Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  2. UK
    1. UK Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. UK Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. UK Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. UK Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  3. France
    1. France Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. France Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. France Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. France Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  4. Spain
    1. Spain Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Spain Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Spain Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Spain Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  5. Italy
    1. Italy Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Italy Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Italy Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Italy Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  6. BENELUX
    1. BENELUX Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. BENELUX Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. BENELUX Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. BENELUX Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  7. Rest of Europe
    1. Rest Of Europe Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Rest Of Europe Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Rest Of Europe Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Rest Of Europe Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
Asia Pacific Human Insulin Market - Segment Analysis
1. Overview
2. Asia Pacific Human Insulin Market, 2016 - 2028 (USD Million)
3. Asia Pacific Human Insulin Market, by Product
  1. By Drugs
  2. By Delivery Devices
4. Asia Pacific Human Insulin Market, by Product Type
  1. By Insulin Analoys & Biosimilars
  2. By Human Insulin Biologics
5. Asia Pacific Human Insulin Market, by Diabetes Type
  1. By Diabetes 1
  2. By Diabetes 2
6. Asia Pacific Human Insulin Market, by Delivery Devices
  1. By Pens
  2. By Pen Needles
  3. By Syringes
7. Asia Pacific Human Insulin Market, by Country
  1. China
    1. China Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. China Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. China Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. China Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  2. Japan
    1. Japan Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Japan Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Japan Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Japan Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  3. India
    1. India Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. India Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. India Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. India Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  4. South Korea
    1. South Korea Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. South Korea Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. South Korea Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. South Korea Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  5. South East Asia
    1. South East Asia Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. South East Asia Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. South East Asia Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. South East Asia Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Rest of Asia Pacific Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Rest of Asia Pacific Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Rest of Asia Pacific Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
Latin America Human Insulin Market - Segment Analysis
1. Overview
2. Latin America Human Insulin Market, 2016 - 2028 (USD Million)
3. Latin America Human Insulin Market, by Product
  1. By Drugs
  2. By Delivery Devices
4. Latin America Human Insulin Market, by Product Type
  1. By Insulin Analoys & Biosimilars
  2. By Human Insulin Biologics
5. Latin America Human Insulin Market, by Diabetes Type
  1. By Diabetes 1
  2. By Diabetes 2
6. Latin America Human Insulin Market, by Delivery Devices
  1. By Pens
  2. By Pen Needles
  3. By Syringes
7. Latin America Human Insulin Market, by Country
  1. Brazil
    1. Brazil Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Brazil Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Brazil Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Brazil Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  2. Argentina
    1. Argentina Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Argentina Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Argentina Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Argentina Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  3. Rest of Latin America
    1. Rest of Latin America Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Rest of Latin America Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Rest of Latin America Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Rest of Latin America Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
Middle East & Africa Human Insulin Market - Segment Analysis
1. Overview
2. Middle East & Africa Human Insulin Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Human Insulin Market, by Product
  1. By Drugs
  2. By Delivery Devices
4. Middle East & Africa Human Insulin Market, by Product Type
  1. By Insulin Analoys & Biosimilars
  2. By Human Insulin Biologics
5. Middle East & Africa Human Insulin Market, by Diabetes Type
  1. By Diabetes 1
  2. By Diabetes 2
6. Middle East & Africa Human Insulin Market, by Delivery Devices
  1. By Pens
  2. By Pen Needles
  3. By Syringes
7. Middle East & Africa Human Insulin Market, by Country
  1. GCC Countries
    1. GCC Countries Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. GCC Countries Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. GCC Countries Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. GCC Countries Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  2. South Africa
    1. South Africa Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. South Africa Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. South Africa Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. South Africa Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Human Insulin Market, By Product
      1. By Drugs
      2. By Delivery Devices
    2. Rest of Middle East & Africa Human Insulin Market, By Product Type
      1. By Insulin Analoys & Biosimilars
      2. By Human Insulin Biologics
    3. Rest of Middle East & Africa Human Insulin Market, By Diabetes Type
      1. By Diabetes 1
      2. By Diabetes 2
    4. Rest of Middle East & Africa Human Insulin Market, By Delivery Devices
      1. By Pens
      2. By Pen Needles
      3. By Syringes
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Novo Nordisk A/S (Denmark)
2. Eli Lilly & Company (US)
3. Boston Scientific Corporation (US)
4. Sanofi (France)
5. Boehringer Ingelheim International GmbH (Germany)
6. Biocon (India)
7. Tonghua Dongbao Pharmaceutical (China)
8. Julphar (UAE)
9. Wockhardt (India)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

ESOMAR

DUN

Trust Wave

Vantage Market Research | 01-Dec-2022

“Human Insulin Market to Reach Valuation of USD 26.9 Billion by 2028 –Increased Launch of Novel Human Insulin Products Drives the Market”

FAQ

Frequently Asked Question

What is the global demand for Human Insulin in terms of revenue?

The global Human Insulin valued at USD 22.66 Billion in 2022 and is expected to reach USD 28.71 Billion in 2030 growing at a CAGR of 3.00%.

Which are the prominent players in the market?

The prominent players in the market are Novo Nordisk A/S (Denmark), Eli Lilly & Company (US), Boston Scientific Corporation (US), Sanofi (France), Boehringer Ingelheim International GmbH (Germany), Biocon (India), Tonghua Dongbao Pharmaceutical (China), Julphar (UAE), Wockhardt (India).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 3.00% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Human Insulin include
- Increase in prevalence of diabetes

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Human Insulin in 2022.

Name

Email

Company

Phone

Message

Captcha

I Accept Terms & Condition TnC

Your personal information will be kept confidential. Privacy Policy

Chat with usLiveChat